Openevidence
Openevidence is a healthcare-focused AI company that provides a search and reasoning platform over medical literature to help clinicians and medical students quickly find evidence-based answers to clinical questions. Its product ingests and structures peer‑reviewed research and guidelines, then uses large language models to generate traceable, citation-backed responses. The company monetizes through subscriptions and institutional licenses to medical schools, hospitals, and healthcare organizations.
- Revenue
- <$10M
- Employees
- 1 - 50
- Founded
- 2023
- Headquarters
- New York City, United States of America
Openevidence customers on Arbolus
Customers who reviewed Openevidence
Seniority of Openevidence customers
Most people who reviewed Openevidence hold C-Suite roles (57%), followed by Director (27%) and Manager (16%).
- C-Suite 57%
- Director 27%
- Manager 16%
Customers sample
Employer names and spend open in the full report, along with the other 51 customers.
What 54 Arbolus experts think of Openevidence
Overall sentiment: Positive
NPS is highly positive, with 80.8% promoters, 15.4% passives, and only 3.8% detractors, resulting in an NPS score of 76.9. Renewal intent is strong, with 66.7% of respondents likely to renew and only 8.3% unlikely. Stickiness is high, with 53.8% using the platform for more than a year and 40.4% for less than a year. Expert feedback highlights strengths in evidence transparency, workflow integration, and academic credibility, with minor concerns about versatility and specialty coverage.
Everything 54 customers told us about Openevidence.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
79 Net Promoter Score, from 54 scored reviews- Promoters 44
- Passives 9
- Detractors 1
Praised
- Evidence Transparency and Source Credibility
- Time Savings and Workflow Efficiency
- Rapid Access to Evidence-Based Information
- Expansion into Board Preparation
Criticised
- Limited Versatility Compared to Competitors
- Need for Independent Verification
- Risk of Replacement by More Versatile AI Platforms
What Openevidence customers say
Evidence Transparency and Source Credibility
“I still highly recommend Open Evidence to most of my peers. It is still probably the most trustworthy AI chatbot. I say this because they were the first to really integrate with evidence-based responses and direct links to primary sources. They were also collaborating with MIT, Harvard, and other large academic institutions, which improved their credibility.”
Time Savings and Workflow Efficiency
“I rely on OpenEvidence because it makes it faster to find and understand medical research without having to search through multiple sources myself. The biggest value is saving time while still being able to see the evidence behind the information.”
Rapid Access to Evidence-Based Information
“I would recommend OpenEvidence to fellow nurse practitioners for its ease of use, rapid access to evidence-based information, and ability to synthesize complex research into practical clinical insights. It is particularly helpful for answering clinical questions, reviewing guidelines, and supporting point-of-care decisions.”
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 63% 8 answers
- 100% 2 answers
- 0% 1 answer
- 100% 1 answer
- 9.5/10 Average score from customers who will renew
- 8/10 Average score from undecided customers
- 4/10 Average score from customers not renewing
Top alternatives
Most weighed by Openevidence customersReport
For people who use Openevidence
Do you use Openevidence at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 54 customers of Openevidence have already contributed
Takes a few minutes. Your identity stays anonymous.